These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 19024888

  • 1. Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008.
    Glah D, Tear S.
    IDrugs; 2008 Nov; 11(11):841-5. PubMed ID: 19024888
    [No Abstract] [Full Text] [Related]

  • 2. Deals landscape: notable deals in the pharmaceutical industry in the first quarter of 2008.
    Shumoogam J, Al-Shamahi A.
    IDrugs; 2008 May; 11(5):351-5. PubMed ID: 18465677
    [Abstract] [Full Text] [Related]

  • 3. Deals landscape: notable deals in the pharmaceutical industry in the second quarter of 2008.
    Bright J, Lakeram M.
    IDrugs; 2008 Aug; 11(8):584-91. PubMed ID: 18724496
    [No Abstract] [Full Text] [Related]

  • 4. Deal watch: Bristol-Myers Squibb and Exelixis collaborate on kinase inhibitors.
    Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180098
    [No Abstract] [Full Text] [Related]

  • 5. Government action needed to step up research and development for world's most neglected diseases.
    Pecoul B.
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):841-3. PubMed ID: 16307495
    [No Abstract] [Full Text] [Related]

  • 6. Notable deals in the pharmaceutical industry in the fourth quarter of 2016.
    D'Souza P.
    Drugs Today (Barc); 2017 Jan; 53(1):75-82. PubMed ID: 28387386
    [Abstract] [Full Text] [Related]

  • 7. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI, Revel L, Rosa E, Cruces E.
    Drug News Perspect; 2009 Jan; 22(1):39-51. PubMed ID: 19209298
    [Abstract] [Full Text] [Related]

  • 8. Drug life-cycle technologies.
    Fleming E, Ma P.
    Nat Rev Drug Discov; 2002 Oct; 1(10):751-2. PubMed ID: 12360253
    [No Abstract] [Full Text] [Related]

  • 9. Pharmaceutical sciences in 2020.
    Crommelin D, Stolk P, Besançon L, Shah V, Midha K, Leufkens H.
    Nat Rev Drug Discov; 2010 Feb; 9(2):99-100. PubMed ID: 20118959
    [No Abstract] [Full Text] [Related]

  • 10. World of scientific medicine.
    Hegde BM.
    J Assoc Physicians India; 1998 Aug; 46(8):732-3. PubMed ID: 11229286
    [No Abstract] [Full Text] [Related]

  • 11. Pharmaceutical R&D: the road to positive returns.
    David E, Tramontin T, Zemmel R.
    Nat Rev Drug Discov; 2009 Aug; 8(8):609-10. PubMed ID: 19644471
    [No Abstract] [Full Text] [Related]

  • 12. Overcoming further challenges in the pharma/biotech industry: 2007 update.
    Graul AI, Cruces E, Revel L, Serradell N, Rosa E.
    Drug News Perspect; 2008 Aug; 21(1):44-58. PubMed ID: 18301809
    [Abstract] [Full Text] [Related]

  • 13. Drug research--a change of paradigms.
    Müllner S.
    Arzneimittelforschung; 1997 Jan; 47(1):105. PubMed ID: 9037454
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Open innovation: share or die..
    Talaga P.
    Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Industrial R&D paradigm shift to vaccines.
    Maggon K.
    Biotechnol J; 2009 Apr; 4(4):458-61. PubMed ID: 19370719
    [No Abstract] [Full Text] [Related]

  • 20. Notable deals in the pharmaceutical industry in the first quarter of 2017.
    Cruces E.
    Drugs Today (Barc); 2017 Jun; 53(6):357-365. PubMed ID: 28799581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.